Cardiac fibroblasts regulate cardiomyocyte hypertrophy through dynamic regulation of type I collagen
Q. Meng, S. L. K. Bowers, Y. Kuwabara, J. Huo, R. Minerath, A. J. York, M. A. Sargent, V. Prasad, A. J. Saviola, D. C. Galindo, K. C. Hansen, R. J. Vagnozzi, K. E. Yutzey, J. D. Molkentin
Abstract
RationaleCardiomyocytes and fibroblasts in the heart communicate through both secreted growth factors as well as through sensing the structural properties of the extracellular matrix that each helps generate. Previous studies have shown that defects in fibroblast activity during disease stimulation result in altered cardiomyocyte hypertrophy, although the role that collagen might play in this communication is unknown. ObjectiveHere we investigated how type I collagen maturation and disease-responsive matrix expansion in the heart by cardiac fibroblasts impacts cardiac fibrosis and cardiomyocyte hypertrophy. Methods and ResultsWe generated and characterized Col1a2-/- mice using standard gene-targeting. Col1a2-/- mice were viable, although by young adulthood their hearts showed alterations in extracellular matrix mechanical properties, as well as an unanticipated activation of cardiac fibroblasts and induction of a progressive fibrotic response. This included increases in fibroblast number and a progressive cardiac hypertrophy, with reduced functional performance by 9 months. Col1a2-loxP targeted mice were also generated and crossed with the tamoxifen-inducible Postn-MerCreMer knock-in mice to delete the Col1a2 gene in myofibroblasts post-pressure overload injury, to more specifically implicate fibroblasts as effectors of cardiomyocyte hypertrophy in vivo. Opposite to the gradual induction of cardiac hypertrophy observed in germline Col1a2-/- mice as they matured developmentally, adult fibroblast-specific deletion of Col1a2 during pressure overload protected these mice from cardiac hypertrophy in the first week with a delayed fibrotic response. However, this reduction in hypertrophy due to myofibroblast-specific Col1a2 deletion was gradually lost over 2 and 6 weeks of pressure overload as augmented fibrosis returned. ConclusionsDefective type I collagen in the developing heart alters the structural integrity of the extracellular matrix that leads to fibroblast expansion, activation, fibrosis and hypertrophy with progressive cardiomyopathy in adulthood. However, acute deletion of type I collagen production for the first time in the adult heart during pressure overload prevents ECM expansion and inhibits cardiomyocyte hypertrophy, while gradual restoration of fibrosis again permitted hypertrophy comparable to controls.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Consequences of PDGFRα+ fibroblast reduction in adult murine hearts
J. T. Kuwabara, S. Bhutada, … M. D. Tallquist·bioRxiv·May 7, 2021
- Cardiomyocyte-expressed TGFβ signals to fibroblasts to program early heart maturation and adult myocyte identity
Rachel A Minerath, Rajesh K. Kasam, … Jeffery D. Molkentin·bioRxiv·Sep 22, 2025
- Cardiac Fibroblasts regulate myocardium and coronary vasculature development via the collagen signaling pathway
Yiting Deng, Yuanhang He, … Guang Li·bioRxiv·Sep 11, 2024
- Genetic deletion of cytoglobin exacerbates cardiac hypertrophy and inhibits cardiac fibroblast activation independent of changes in blood pressure
Le Gia Cat Pham, Kurrim Gilliard, … David Jourd’heuil·American Journal of Physiology-Heart and Circulatory PhysiologyPeer-reviewed·Jun 1, 2026
- FAM114A1 Influences Cardiac Fibrosis by Regulating Angiotensin II Signaling in Cardiac Fibroblasts
K. C. V. Subbaiah, J. Wu, … P. Yao·bioRxiv·Feb 20, 2021
- Correcting dilated cardiomyopathy with fibroblast-targeted p38 deficiency
R. C. Bretherton, I. M. Reichardt, … J. Davis·bioRxiv·Jan 23, 2023